{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:09:04Z","timestamp":1791925744888,"version":"4.3.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["no.BT\/INF\/22\/SP33063\/2019"],"award-info":[{"award-number":["no.BT\/INF\/22\/SP33063\/2019"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.neuroscience.2025.05.021","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:01:50Z","timestamp":1747162910000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"577","author":[{"given":"N.S","family":"Aathira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Mehdi","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nimisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinki","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atri","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep Singh","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.05.021_b0005","unstructured":"World Health Organization . Dementia: Key facts. Accessed Nov 15, 2024. Available at: https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/dementia."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0010","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Special report. Mapping a better future for dementia care navigation. Accessed online on August 4, 2024 from https:\/\/www.alz.org\/media\/Documents\/alzheimers-facts-and-figures.pdf."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0015","unstructured":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 Nichols, Emma et al. The Lancet Public Health, Volume 7, Issue 2, e105 - e125."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0020","unstructured":"Dementia statistics | Alzheimer\u2019s Disease International (ADI)."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.05.021_b0025","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer\u2019s disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol Neurodegeneration"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s Disease Risk Genes and Mechanisms of Disease Pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol Psychiatry."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0040","doi-asserted-by":"crossref","unstructured":"K\u00f6nig, T., & St\u00f6gmann, E. (2021). Genetics of Alzheimer\u2019s disease. Genetik der Alzheimer-Demenz. Wiener medizinische Wochenschrift (1946), 171(11-12), 249\u2013256. https:\/\/doi.org\/10.1007\/s10354-021-00819-9.","DOI":"10.1007\/s10354-021-00819-9"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0045","doi-asserted-by":"crossref","unstructured":"Lanoisel\u00e9e H-M, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases PLoS Med 14 3 2017 10.1371\/journal. pmed.1002270 e1002270.","DOI":"10.1371\/journal.pmed.1002270"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0050","article-title":"Difficult case of a rare form of familial Alzheimer\u2019s disease with PSEN1 P117L mutation","volume":"11","author":"Rocha","year":"2018","journal-title":"BMJ Case Reports CP"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0055","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Special report. Mapping a better future for dementia care navigation. Accessed online on August 4, 2024 from https:\/\/www.alz.org\/media\/Documents\/alzheimers-facts-and-figures.pdf."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0060","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/s41467-024-46344-2","article-title":"The effects of genetic and modifiable risk factors on brain regions vulnerable to ageing and disease","volume":"15","author":"Manuello","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0065","doi-asserted-by":"crossref","unstructured":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Published: July 30, 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0070","unstructured":"National Down Syndrome Society. Alzheimer\u2019s Disease and Down Syndrome. Available at: https:\/\/www.ndss.org\/resources\/ alzheimers\/. Accessed December 15, 2023."},{"issue":"21","key":"10.1016\/j.neuroscience.2025.05.021_b0075","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer\u2019s disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.643115","article-title":"Differential effects of the six human TAU isoforms: somatic retention of 2N-TAU and increased microtubule number induced by 4R-TAU","volume":"15","author":"Bachmann","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.05.021_b0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jcp.22842","article-title":"Tau splicing and the intricacies of dementia","volume":"227","author":"Andreadis","year":"2012","journal-title":"Journal of Cellular Physiology"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.05.021_b0100","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/alz.12452","article-title":"Current directions in tau research: Highlights from Tau 2020","volume":"18","author":"Sexton","year":"2022","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00476-x","article-title":"Cellular and pathological heterogeneity of primary tauopathies","volume":"16","author":"Chung","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.05.021_b0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: new perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.05.021_b0120","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s00415-024-12314-3","article-title":"Genetic forms of tauopathies: Inherited causes and implications of Alzheimer\u2019s disease-like TAU pathology in primary and secondary tauopathies","volume":"271","author":"Langerscheidt","year":"2024","journal-title":"Journal of Neurology"},{"issue":"14","key":"10.1016\/j.neuroscience.2025.05.021_b0125","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in Alzheimer\u2019s disease\u2014A potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.05.021_b0130","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/cells11121963","article-title":"Dysregulated Ca2+ homeostasis as a central theme in neurodegeneration: lessons from Alzheimer\u2019s disease and Wolfram syndrome","volume":"11","author":"Callens","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2023.102757","article-title":"Mitochondrial Ca2+ signaling and Alzheimer\u2019s disease: Too much or too little?","volume":"113","author":"Garcia-Casas","year":"2023","journal-title":"Cell Calcium"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.05.021_b0140","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3390\/cells9122655","article-title":"Ca2+ dyshomeostasis disrupts neuronal and synaptic function in Alzheimer\u2019s disease","volume":"9","author":"McDaid","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0145","doi-asserted-by":"crossref","unstructured":"Z.S. Khachaturian, Calcium hypothesis of Alzheimer\u2019s disease and brain aging, Ann. N. Y. Acad. Sci. 747 (1994) 1\u201311. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/q uery.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7847664. In.","DOI":"10.1111\/j.1749-6632.1994.tb44398.x"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0150","first-page":"13","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease","volume":"18","author":"Misrani","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.05.021_b0155","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1083\/jcb.201707070","article-title":"Lysosomes convene to keep the synapse clean","volume":"216","author":"Kononenko","year":"2017","journal-title":"Journal of Cell Biology."},{"issue":"24","key":"10.1016\/j.neuroscience.2025.05.021_b0160","first-page":"E4859","article-title":"Contacts between the endoplasmic reticulum and other membranes in neurons","volume":"114","author":"Wu","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-022-00404-3","article-title":"Inflammation context in Alzheimer\u2019s disease, a relationship intricate to define","volume":"55","author":"Novoa","year":"2022","journal-title":"Biological Research"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12979-022-00300-0","article-title":"Different phenotypes of microglia in animal models of Alzheimer disease","volume":"19","author":"Wei","year":"2022","journal-title":"Immunity & Ageing"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.05.021_b0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.05.021_b0180","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0185","first-page":"5","article-title":"Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms","volume":"20","author":"Kober","year":"2016","journal-title":"Elife."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.05.021_b0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer\u2019s disease","volume":"34","author":"Griciuc","year":"2021","journal-title":"Curr Opin Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-025-00828-x","article-title":"Immune modulation to treat Alzheimer\u2019s disease","volume":"20","author":"Duggan","year":"2025","journal-title":"Mol Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-015-0041-1","article-title":"The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration","volume":"4","author":"Hu","year":"2015","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0205","doi-asserted-by":"crossref","unstructured":"Goyal MS, Raichle ME. Glucose Requirements of the Developing Human Brain. J Pediatr Gastroenterol Nutr. 2018 Jun;66(S3).","DOI":"10.1097\/MPG.0000000000001875"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.05.021_b0210","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.3390\/ijms24043506","article-title":"How can insulin resistance cause Alzheimer\u2019s disease?","volume":"24","author":"Yoon","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110112","article-title":"Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer\u2019s disease","volume":"106","author":"Goyal","year":"2021","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.05.021_b0220","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/cns.12866","article-title":"Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment","volume":"24","author":"Pomytkin","year":"2018","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"18","key":"10.1016\/j.neuroscience.2025.05.021_b0225","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.3390\/ijms22189987","article-title":"Insulin and insulin resistance in Alzheimer\u2019s disease","volume":"22","author":"S\u0119dzikowska","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s41983-023-00751-2","article-title":"Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta inhibition","volume":"59","author":"Limantoro","year":"2023","journal-title":"Egypt J Neurol Psychiatr Neurosurg."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0235","first-page":"13","article-title":"The Link Between Tau and Insulin Signaling: Implications for Alzheimer\u2019s Disease and Other Tauopathies","volume":"5","author":"Gon\u00e7alves","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0240","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1007\/s11033-020-05693-z","article-title":"An update on potential links between type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"47","author":"De Sousa","year":"2020","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0245","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","article-title":"The genetic landscape of Alzheimer disease","volume":"148","author":"Carmona","year":"2018","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.24305","article-title":"Coding mutations in SORL1 and Alzheimer disease","volume":"77","author":"Vardarajan","year":"2015","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.05.021_b0255","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","article-title":"TREM2 promotes microglial survival by activating Wnt\/\u03b2-catenin pathway","volume":"37","author":"Zheng","year":"2017","journal-title":"J Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-022-00592-2","article-title":"Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer\u2019s disease related proteins","volume":"18","author":"Oatman","year":"2023","journal-title":"Mol Neurodegener."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0265","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz022","article-title":"Genetic variability in response to amyloid beta deposition influences Alzheimer\u2019s disease risk","volume":"1","author":"Salih","year":"2019","journal-title":"Brain Communications"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101126","article-title":"From beta amyloid to altered proteostasis in Alzheimer\u2019s disease","volume":"64","author":"Bruni","year":"2020","journal-title":"Ageing Research Reviews"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.05.021_b0275","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41582-021-00565-x","article-title":"Changing demography and the challenge of dementia in India","volume":"17","author":"Ravindranath","year":"2021","journal-title":"Nature Reviews. Neurology"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.05.021_b0280","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat Rev Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.05.021_b0290","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat Med."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0295","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2015.02.040","article-title":"Genetic associations of CLU rs9331888 polymorphism with Alzheimer\u2019s disease: A meta-analysis","volume":"591","author":"Shuai","year":"2015","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.05.021_b0300","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10072-018-3259-8","article-title":"Association between CLU gene rs11136000 polymorphism and Alzheimer\u2019s disease: an updated meta-analysis","volume":"39","author":"Zhu","year":"2018","journal-title":"Neurological Sciences\u00a0: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.05.021_b0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.15171\/bi.2019.27","article-title":"Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer\u2019s disease","volume":"9","author":"Mehdizadeh","year":"2019","journal-title":"BioImpacts\u00a0: BI"},{"issue":"24","key":"10.1016\/j.neuroscience.2025.05.021_b0310","doi-asserted-by":"crossref","first-page":"13647","DOI":"10.3390\/ijms222413647","article-title":"Complement system in Alzheimer\u2019s disease","volume":"22","author":"Shah","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2012.08.032","article-title":"Association of the CR1 polymorphism with late-onset Alzheimer\u2019s disease in Chinese Han populations: a meta-analysis","volume":"527","author":"Jin","year":"2012","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0320","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.psychres.2019.01.081","article-title":"Association study of the ABCA7 rs3752246 polymorphism in Alzheimer\u2019s disease","volume":"279","author":"Feh\u00e9r","year":"2019","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.05.021_b0325","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","article-title":"APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry","volume":"80","author":"Belloy","year":"2023","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.05.021_b0330","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/etm.2021.9778","article-title":"The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer\u2019s disease: A systematic review and meta\u2013analysis","volume":"21","author":"Li","year":"2021","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137400","article-title":"CD33 polymorphisms and Parkinson\u2019s disease Parkinson\u2019s disease in northern Chinese Han population: A case-control study","volume":"812","author":"Tian","year":"2023","journal-title":"Neurosci Lett."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.05.021_b0340","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/atm.2018.04.21","article-title":"Meta-analysis of the association between CD33 and Alzheimer\u2019s disease","volume":"6","author":"Jiang","year":"2018","journal-title":"Ann Transl Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0345","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1038\/s41598-018-29450-2","article-title":"Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer\u2019s Disease in Caucasian But Not Chinese population","volume":"8","author":"Han","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JAD-215306","article-title":"ABCA7, a Genetic Risk Factor Associated with Alzheimer\u2019s Disease Risk in African Americans","volume":"86","author":"Stepler","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"23","key":"10.1016\/j.neuroscience.2025.05.021_b0355","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.3390\/ijms222313012","article-title":"miRNAs as Therapeutic Tools in Alzheimer\u2019s Disease","volume":"22","author":"Lee","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.05.021_b0360","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jmb.2019.01.046","article-title":"Emerging Role of microRNAs in Dementia","volume":"431","author":"Ramakrishna","year":"2019","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0365","doi-asserted-by":"crossref","unstructured":"C.A. Ju\u017awik S. Drake S, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A, et al. microRNA dysregulation in neurodegenerative diseases: A systematic review Prog Neurobiol. 182 2019 Nov 101664.","DOI":"10.1016\/j.pneurobio.2019.101664"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.05.021_b0370","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800169","article-title":"Too Many False Targets for MicroRNAs: Challenges and Pitfalls in Prediction of miRNA Targets and Their Gene Ontology in Model and Non\u2010model Organisms","volume":"41","author":"Fridrich","year":"2019","journal-title":"BioEssays."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0375","first-page":"291","article-title":"Inconsistencies and Limitations of Current MicroRNA Target Identification Methods","author":"Mockly","year":"2019","journal-title":"In"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.05.021_b0380","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/15476286.2017.1320469","article-title":"Issues in current microRNA target identification methods","volume":"14","author":"Seitz","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2014.04.026","article-title":"MicroRNA-135a and-200b, potential Biomarkers for Alzheimer\u05f3 s disease, regulate \u03b2 secretase and amyloid precursor protein","volume":"1583","author":"Liu","year":"2014","journal-title":"Brain Research"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.05.021_b0390","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/s41380-019-0610-2","article-title":"MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"26","author":"Chopra","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0395","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1038\/s41598-022-05164-4","article-title":"Effects of microRNA-298 on APP and BACE1 translation differ according to cell type and 3\u2032-UTR variation","volume":"12","author":"Wang","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.neuroscience.2025.05.021_b0400","doi-asserted-by":"crossref","unstructured":"Wang R, Maloney B, Nho K, Beck J, Counts SE, Lahiri DK. Human microRNA-153-3p targets specific neuronal genes and is associated with the risk of Alzheimer\u2019s disease. 2024.","DOI":"10.1101\/2024.09.07.611728"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.05.021_b0405","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/omi.2016.0099","article-title":"Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer\u2019s Disease?","volume":"20","author":"Y\u0131lmaz","year":"2016","journal-title":"OMICS."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0410","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","article-title":"miR-29c regulates BACE1 protein expression","volume":"1395","author":"Zong","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0415","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mecha nisms and functions of pyroptosis, inflammatory caspases and in flammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunological Reviews"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.05.021_b0420","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1627","article-title":"Mechanism of microRNA\u201022 in regulating neuroinflammation in Alzheimer\u2019s disease","volume":"10","author":"Han","year":"2020","journal-title":"Brain and Behavior"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.05.021_b0425","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1523\/JNEUROSCI.4571-15.2016","article-title":"Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer\u2019s Disease","volume":"36","author":"Jaouen","year":"2016","journal-title":"The Journal of Neuroscience."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105805","article-title":"The role of microRNA-34 family in Alzheimer\u2019s disease: A potential molecular link between neurodegeneration and metabolic disorders","volume":"172","author":"Bazrgar","year":"2021","journal-title":"Pharmacol Res."},{"issue":"19","key":"10.1016\/j.neuroscience.2025.05.021_b0435","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/hmg\/ddn201","article-title":"A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex","volume":"17","author":"Mellios","year":"2008","journal-title":"Hum Mol Genet."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00595-7","article-title":"The gut microbiome in Alzheimer\u2019s disease: what we know and what remains to be explored","volume":"18","author":"Chandra","year":"2023","journal-title":"Mol. Neurodegener.,"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.05.021_b0445","first-page":"739","article-title":"ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer\u2019s Disease","volume":"42","author":"Jeong","year":"2019","journal-title":"Mol Cells."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.05.021_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109259","article-title":"SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network","volume":"35","author":"Hung","year":"2021","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.neuroscience.2025.05.021_b0455","doi-asserted-by":"crossref","first-page":"20862","DOI":"10.18632\/aging.104104","article-title":"TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K\/AKT\/FoxO3a signaling pathway in Alzheimer\u2019s disease mice","volume":"12","author":"Wang","year":"2020","journal-title":"Aging."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.05.021_b0460","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-024-00720-0","article-title":"Gut microbiota-host lipid crosstalk in Alzheimer\u2019s disease: implications for disease progression and therapeutics","volume":"19","author":"Luo","year":"2024","journal-title":"Mol Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.05.021_b0465","doi-asserted-by":"crossref","unstructured":"Seo D oh, Holtzman DM. Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med. 2024 Jan 4;56(1):86\u201394.","DOI":"10.1038\/s12276-023-01146-2"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225003732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225003732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:30:48Z","timestamp":1778538648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225003732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":93,"alternative-id":["S0306452225003732"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.05.021","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}